BRD-K53581288-001-02-9
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A007 HELA 24H J22 baricitinib 0.37um.tsv.gz
uterine cervix
Label
Description
A Substance
A 161 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project